| 2025 |
Efficacy, safety, and economic evaluation of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a randomized, double-blind, placebo-controlled, parallel, multicenter, investigator-initiated clinical trial |
| 2025 |
Review of Randomized Controled Trials on Herbal Medicine for Influenza Prevention |
| 2024 |
Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Randomized, Double-Blinded, Placebo-Controlled, Phase II Trial |
| 2024 |
Efficacy and safety of USL for dry eye disease: protocol for a randomized, double-blind, placebo-controlled, parallel, phase 2 clinical trial |
| 2023 |
Efficacy and Safety of Yukmijihwang-tang in the Treatment of Cough-Variant Asthma: Study Protocol for a Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Trial |
| 2023 |
Efficacy, Safety and Economic Evaluation of Wolbigachul-Tang for Chronic Cough due to Upper Airway Cough Syndrome (UACS): A Study Protocol for Randomized, Double-Blind, Active-Comparator Controlled, Parallel, Exploratory Clinical Trial |
| 2022 |
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial |
| 2022 |
The effect of lung-conduction exercise in chronic obstructive pulmonary disease: Randomized, assessor-blind, multicenter pilot trial |
| 2022 |
Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: a pilot, randomized, double-blind, placebo-controlled trial |
| 2022 |
Herbal medicines for the treatment of chronic obstructive airways diseases (asthma or chronic obstructive pulmonary disease): a prospective observational study |
| 2022 |
Electroacupuncture for cancer-related cognitive impairment: a feasibility clinical study |
| 2022 |
Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial |
| 2021 |
Clinical Research Trends of Gut Microbiome for Respiratory Diseases |
| 2021 |
Inhibitory effects of modified gamgil-tang in a particulate matter-induced lung injury mouse model |
